Galmed Pharmaceuticals's total assets for Q4 2023 were $16.63M, an increase of 0.41% from the previous quarter. GLMD total liabilities were $2.75M for the fiscal quarter, a -12.36% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.